The global bioprocess technology market reached USD 31.2 billion in 2024. IMARC Group projects the market to grow at a CAGR of 6.65% from 2025 to 2033, reaching USD 55.7 billion by 2033. This growth is driven by increasing biopharmaceutical production, advancements in biotechnology, and rising demand for innovative therapeutic and diagnostic solutions. https://www.imarcgroup.com/bioprocess-technology-market